Centanafadine for Attention-Deficit/Hyperactivity Disorder in Adolescents: A Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Centanafadine for Attention-Deficit/Hyperactivity Disorder in Adolescents: A Randomized Clinical Trial.
Authors: Ward CL; Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, Maryland., Childress AC; Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, Nevada., Jin N; Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, Maryland., Turkoglu O; Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, Maryland., Skubiak T; Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, Maryland., Wilens TE; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: twilens@mgh.harvard.edu.
Source: Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2026 Jun; Vol. 65 (6), pp. 805-817. Date of Electronic Publication: 2025 Jul 04.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 8704565 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-5418 (Electronic) Linking ISSN: 08908567 NLM ISO Abbreviation: J Am Acad Child Adolesc Psychiatry Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-5418
DOI:10.1016/j.jaac.2025.06.023